TESARO
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed P... hase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.
TESARO
Industry:
Biopharma Biotechnology Health Care Oncology
Founded:
2010-03-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.tesarobio.com
Total Employee:
101+
Status:
Closed
Contact:
339.970.0900
Total Funding:
1.1 B USD
Technology used in webpage:
Domain Not Resolving LetsEncrypt Mobile Non Scaleable Content HSTS IPv6 Google Google Cloud ASP.NET IIS Microsoft
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - TESARO
Johnson & Johnson
Johnson & Johnson investment in Post-IPO Equity - TESARO
InterWest Partners
InterWest Partners investment in Post-IPO Equity - TESARO
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - TESARO
Kleiner Perkins
Kleiner Perkins investment in Post-IPO Equity - TESARO
Future Fund
Future Fund investment in Post-IPO Equity - TESARO
Sofinnova Investments
Sofinnova Investments investment in Series C - TESARO
New Enterprise Associates
New Enterprise Associates investment in Series B - TESARO
Pappas Ventures
Pappas Ventures investment in Series B - TESARO
Oracle Capital Partners
Oracle Capital Partners investment in Series B - TESARO
Newest Events participated
Official Site Inspections
http://www.tesarobio.com
- Host name: 158.246.120.34.bc.googleusercontent.com
- IP address: 34.120.246.158
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "TESARO"
TESARO - Crunchbase Company Profile & Funding
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer. View contacts for TESARO to access new leads and connect with decision-makers.See details»
Tesaro - Wikipedia
Tesaro was founded in 2010. The company's first commercial product, Varubi, was approved by the FDA in October 2015. As of 2016, the company had 286 full-time employees, 59 of whom had a PhD or MD. The company's product Niraparib was granted priority review and was given a target action date of June 2017 by the FDA. In March 2017, Tesaro won approval for its drug Zejula to treat ovarian cancer. On May 31, 2017, it was reported that Tesaro Inc. was exploring …See details»
TESARO, Inc. Management Team | Org Chart - RocketReach
TESARO, Inc. employs 102 employees. The TESARO, Inc. management team includes Barbara Staples (Associate Director, Regulatory CMC), Ping Wang (Director Biostatistics), and …See details»
TESARO, Inc. Information - RocketReach
TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission that drives all of our actions. We are dedicated to improving the oncology experience and have a …See details»
TESARO, Inc. - LinkedIn
TESARO, Inc. | 31,407 followers on LinkedIn. TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission that drives all of our actions. We are dedicated to …See details»
TESARO, Inc. Overview | SignalHire Company Profile
TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission that drives all of our actions. We are dedicated to improving the oncology experience and have a …See details»
TESARO, Inc. Email Format & Employee Directory | ContactOut
Get details for TESARO, Inc.’s 30 employees, email format for tesarobio.com and phone numbers. TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a …See details»
Tesaro, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Tesarobio.com. Public Company | Subsidiary Company | 2010 | Massachusetts, United States | 500-1,000 | NASDAQ: TSRO | tesarobio.com. Last update 01 Nov 2024. Overview. Pipeline. …See details»
Tesaro Company Profile 2024: Valuation, Investors, …
Tesaro General Information Description. Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product …See details»
TESARO Company Profile - Office Locations, Competitors ... - Craft
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. It develops rolapitant, a potent, selective neurokinin-1 receptor antagonist that …See details»
Tesaro (YG9SB4NDRBJ9)
Https://tesarobio.com. Headquarters Waltham, MA United States . Federal recipient TESARO, INC. ... For Profit Organization Manufacturer of Goods. State of Incorporation DE Country of …See details»
TESARO, Inc. | (339) 970-0900 | Waltham, Massachusetts - AllBiz
The website for TESARO, Inc. is www.tesarobio.com. Q5. What are the annual sales for TESARO, Inc.? TESARO, Inc. has annual sales of approximately USD 25,000,000 - …See details»
Tesaro Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Tesaro. See Tesaro company profile and funding data.See details»
TESARObio - Overview, News & Similar companies | ZoomInfo.com
TESARObio is a company that operates in the Pharmaceuticals industry. It employs 6-10 people and has $1M-$5M of revenue. The company is headquarter ed in Austenwood Ward, …See details»
TESARO Bio GmbH Great Place to Work Switzerland
TESARO Bio GmbH - TESARO, an oncology-focused business within GSK, is devoted to providing transformative therapies to people facing cancer. We see new possibilities to …See details»
Tesaro - VentureRadar
Sunesis has built an experienced drug development organization committed to improving the lives of people with cancer. ... 1,473,272 | tesarobio.com. VentureRadar Popularity. Medium. …See details»
GSK completes acquisition of TESARO, an oncology focused ...
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, …See details»
TESARO Inc | Waltham, United States | TESAROBIO - ResearchGate
Find 34 researchers and browse 3 departments, publications, full-texts, contact details and general information related to TESARO Inc | Waltham, United States | TESAROBIOSee details»
Proud to announce @TESAROBIO CEO... - Life Science Cares
Proud to announce @TESAROBIO CEO Lonnie Moulder has joined our Board of Advisors. Thanks for your support, Lonnie!See details»
TESARO, Inc. Email Format | tesarobio.com Emails
[email protected]: 6.1%. Email Verification Tool Instantly check any TESARO, Inc. email. Get free lookups per month. Verify Top TESARO, Inc. Employees Heidi Krenz Vice President, …See details»